Clinical Trial Update: Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs

View source ↗

Summary

A clinical trial update notes potential neuropsychiatric adverse effects in patients with chronic hepatitis C treated with direct-acting antiviral drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Assiut University | Conditions: Hepatitis C | Status: UNKNOWN